人工心肺のグローバル市場2023~2027:病院、ASC

【英語タイトル】Global Heart-lung Machines Market 2023-2027

Technavioが出版した調査資料(IRTNTR45350-23)・商品コード:IRTNTR45350-23
・発行会社(調査会社):Technavio
・発行日:2023年2月10日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア太平洋、その他地域
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社の本調査レポートによると、世界の人工心肺市場規模が2022年から2027年の間に195.04百万ドルに達すると予測されており、予測期間中に年平均3.89%成長すると見込まれます。本書では人工心肺の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、エンドユーザー別(病院、ASC)分析、用途別(心臓手術、心不全、肺手術)分析、顧客状況、地域別状況(北米、ヨーロッパ、アジア太平洋、その他地域、アメリカ、ドイツ、中国、フランス、日本)分析、成長要因・課題・動向、企業状況、企業分析などの内容を掲載しています。なお、本書には、Axiomtek, Braile Biomedica, Edwards Lifesciences Corp., ELITE LIFECARE, Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, Heart Care India Co., Hemovent GmbH, Jarvik Heart Inc., Koninklijke Philips NVなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析

・世界の人工心肺市場規模:エンドユーザー別
- 病院における市場規模
- ASCにおける市場規模

・世界の人工心肺市場規模:用途別
- 心臓手術における市場規模
- 心不全における市場規模
- 肺手術における市場規模

・地域別状況
- 北米の人工心肺市場規模
- ヨーロッパの人工心肺市場規模
- アジア太平洋の人工心肺市場規模
- その他地域の人工心肺市場規模
- アメリカの人工心肺市場規模
- ドイツの人工心肺市場規模
- 中国の人工心肺市場規模
- フランスの人工心肺市場規模
- 日本の人工心肺市場規模

・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、正確な人工心肺市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

人工心肺の世界市場 2023-2027

Technavio社は、人工心肺市場をモニターしており、2022年から2027年にかけて195.04百万ドルの成長が予測され、予測期間中のCAGRは3.89%で加速すると予測しています。当レポートでは、人工心肺市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。アジアにおける医療ツーリズムの増加、ASC数の増加、組織による啓蒙活動などが市場を牽引しています。

Technavioの人工心肺市場は以下のように区分されます:

・エンドユーザー別:
- 病院
- ASC

・用途別:
- 心臓手術
- 心不全
- 肺手術

・地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、携帯型人工心肺が今後数年間の人工心肺市場の成長を牽引する主な要因の1つであると分析しています。また、モジュラー型人工心肺の開発とオンライン小売の普及が市場の大きな需要につながるとしています。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、人工心肺市場について以下の分野をカバーしています:
- 人工心肺の市場規模
- 人工心肺市場予測
- 人工心肺市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Axiomtek, Braile Biomedica, Edwards Lifesciences Corp., ELITE LIFECARE, Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, Heart Care India Co., Hemovent GmbH, Jarvik Heart Inc., Koninklijke Philips NV, LivaNova Plc, Medtronic Plc, Nipro Corp., Palex Medical SA, RAUMEDIC AG, Saati SpA, SONOTEC GmbH, SynCardia Systems LLC, and Terumo Groupなどの企業情報が含まれています。また、人工心肺市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global heart-lung machines market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global heart-lung machines market 2017 – 2021 ($ million)
o 4.2 End-user Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
o 4.3 Application Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user – Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospitals – Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
o 6.4 ASCs – Market size and forecast 2022-2027
o Exhibit 38: Chart on ASCs – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on ASCs – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on ASCs – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on ASCs – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by End-user
o Exhibit 42: Market opportunity by End-user ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 43: Chart on Application – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Application – Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 45: Chart on Comparison by Application
o Exhibit 46: Data Table on Comparison by Application
o 7.3 Heart surgery – Market size and forecast 2022-2027
o Exhibit 47: Chart on Heart surgery – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Heart surgery – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Heart surgery – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Heart surgery – Year-over-year growth 2022-2027 (%)
o 7.4 Heart failure – Market size and forecast 2022-2027
o Exhibit 51: Chart on Heart failure – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Heart failure – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Heart failure – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Heart failure – Year-over-year growth 2022-2027 (%)
o 7.5 Lung surgery – Market size and forecast 2022-2027
o Exhibit 55: Chart on Lung surgery – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Lung surgery – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Lung surgery – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Lung surgery – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Application
o Exhibit 59: Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share by geography 2022-2027 (%)
o Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 89: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 France – Market size and forecast 2022-2027
o Exhibit 93: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 101: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 Axiomtek
o Exhibit 108: Axiomtek – Overview
o Exhibit 109: Axiomtek – Product / Service
o Exhibit 110: Axiomtek – Key offerings
o 12.4 Braile Biomedica
o Exhibit 111: Braile Biomedica – Overview
o Exhibit 112: Braile Biomedica – Product / Service
o Exhibit 113: Braile Biomedica – Key offerings
o 12.5 Edwards Lifesciences Corp.
o Exhibit 114: Edwards Lifesciences Corp. – Overview
o Exhibit 115: Edwards Lifesciences Corp. – Business segments
o Exhibit 116: Edwards Lifesciences Corp. – Key offerings
o Exhibit 117: Edwards Lifesciences Corp. – Segment focus
o 12.6 ELITE LIFECARE
o Exhibit 118: ELITE LIFECARE – Overview
o Exhibit 119: ELITE LIFECARE – Product / Service
o Exhibit 120: ELITE LIFECARE – Key offerings
o 12.7 Eurosets Srl
o Exhibit 121: Eurosets Srl – Overview
o Exhibit 122: Eurosets Srl – Product / Service
o Exhibit 123: Eurosets Srl – Key offerings
o 12.8 Fresenius Medical Care AG and Co. KGaA
o Exhibit 124: Fresenius Medical Care AG and Co. KGaA – Overview
o Exhibit 125: Fresenius Medical Care AG and Co. KGaA – Business segments
o Exhibit 126: Fresenius Medical Care AG and Co. KGaA – Key news
o Exhibit 127: Fresenius Medical Care AG and Co. KGaA – Key offerings
o Exhibit 128: Fresenius Medical Care AG and Co. KGaA – Segment focus
o 12.9 Getinge AB
o Exhibit 129: Getinge AB – Overview
o Exhibit 130: Getinge AB – Business segments
o Exhibit 131: Getinge AB – Key news
o Exhibit 132: Getinge AB – Key offerings
o Exhibit 133: Getinge AB – Segment focus
o 12.10 Heart Care India Co.
o Exhibit 134: Heart Care India Co. – Overview
o Exhibit 135: Heart Care India Co. – Product / Service
o Exhibit 136: Heart Care India Co. – Key offerings
o 12.11 Hemovent GmbH
o Exhibit 137: Hemovent GmbH – Overview
o Exhibit 138: Hemovent GmbH – Product / Service
o Exhibit 139: Hemovent GmbH – Key offerings
o 12.12 Jarvik Heart Inc.
o Exhibit 140: Jarvik Heart Inc. – Overview
o Exhibit 141: Jarvik Heart Inc. – Product / Service
o Exhibit 142: Jarvik Heart Inc. – Key offerings
o 12.13 LivaNova Plc
o Exhibit 143: LivaNova Plc – Overview
o Exhibit 144: LivaNova Plc – Business segments
o Exhibit 145: LivaNova Plc – Key offerings
o Exhibit 146: LivaNova Plc – Segment focus
o 12.14 Medtronic Plc
o Exhibit 147: Medtronic Plc – Overview
o Exhibit 148: Medtronic Plc – Business segments
o Exhibit 149: Medtronic Plc – Key news
o Exhibit 150: Medtronic Plc – Key offerings
o Exhibit 151: Medtronic Plc – Segment focus
o 12.15 Nipro Corp.
o Exhibit 152: Nipro Corp. – Overview
o Exhibit 153: Nipro Corp. – Business segments
o Exhibit 154: Nipro Corp. – Key offerings
o Exhibit 155: Nipro Corp. – Segment focus
o 12.16 SONOTEC GmbH
o Exhibit 156: SONOTEC GmbH – Overview
o Exhibit 157: SONOTEC GmbH – Product / Service
o Exhibit 158: SONOTEC GmbH – Key offerings
o 12.17 Terumo Group
o Exhibit 159: Terumo Group – Overview
o Exhibit 160: Terumo Group – Business segments
o Exhibit 161: Terumo Group – Key news
o Exhibit 162: Terumo Group – Key offerings
o Exhibit 163: Terumo Group – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 164: Inclusions checklist
o Exhibit 165: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 166: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 167: Research methodology
o Exhibit 168: Validation techniques employed for market sizing
o Exhibit 169: Information sources
o 13.5 List of abbreviations
o Exhibit 170: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global heart-lung machines market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on End-user – Market share 2022-2027 (%)
Exhibits31: Data Table on End-user – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on ASCs – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on ASCs – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on ASCs – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on ASCs – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by End-user ($ million)
Exhibits43: Chart on Application – Market share 2022-2027 (%)
Exhibits44: Data Table on Application – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Application
Exhibits46: Data Table on Comparison by Application
Exhibits47: Chart on Heart surgery – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Heart surgery – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Heart surgery – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Heart surgery – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Heart failure – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Heart failure – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Heart failure – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Heart failure – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Lung surgery – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Lung surgery – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Lung surgery – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Lung surgery – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Application ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2022-2027 (%)
Exhibits62: Data Table on Market share by geography 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity by geography ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Axiomtek – Overview
Exhibits109: Axiomtek – Product / Service
Exhibits110: Axiomtek – Key offerings
Exhibits111: Braile Biomedica – Overview
Exhibits112: Braile Biomedica – Product / Service
Exhibits113: Braile Biomedica – Key offerings
Exhibits114: Edwards Lifesciences Corp. – Overview
Exhibits115: Edwards Lifesciences Corp. – Business segments
Exhibits116: Edwards Lifesciences Corp. – Key offerings
Exhibits117: Edwards Lifesciences Corp. – Segment focus
Exhibits118: ELITE LIFECARE – Overview
Exhibits119: ELITE LIFECARE – Product / Service
Exhibits120: ELITE LIFECARE – Key offerings
Exhibits121: Eurosets Srl – Overview
Exhibits122: Eurosets Srl – Product / Service
Exhibits123: Eurosets Srl – Key offerings
Exhibits124: Fresenius Medical Care AG and Co. KGaA – Overview
Exhibits125: Fresenius Medical Care AG and Co. KGaA – Business segments
Exhibits126: Fresenius Medical Care AG and Co. KGaA – Key news
Exhibits127: Fresenius Medical Care AG and Co. KGaA – Key offerings
Exhibits128: Fresenius Medical Care AG and Co. KGaA – Segment focus
Exhibits129: Getinge AB – Overview
Exhibits130: Getinge AB – Business segments
Exhibits131: Getinge AB – Key news
Exhibits132: Getinge AB – Key offerings
Exhibits133: Getinge AB – Segment focus
Exhibits134: Heart Care India Co. – Overview
Exhibits135: Heart Care India Co. – Product / Service
Exhibits136: Heart Care India Co. – Key offerings
Exhibits137: Hemovent GmbH – Overview
Exhibits138: Hemovent GmbH – Product / Service
Exhibits139: Hemovent GmbH – Key offerings
Exhibits140: Jarvik Heart Inc. – Overview
Exhibits141: Jarvik Heart Inc. – Product / Service
Exhibits142: Jarvik Heart Inc. – Key offerings
Exhibits143: LivaNova Plc – Overview
Exhibits144: LivaNova Plc – Business segments
Exhibits145: LivaNova Plc – Key offerings
Exhibits146: LivaNova Plc – Segment focus
Exhibits147: Medtronic Plc – Overview
Exhibits148: Medtronic Plc – Business segments
Exhibits149: Medtronic Plc – Key news
Exhibits150: Medtronic Plc – Key offerings
Exhibits151: Medtronic Plc – Segment focus
Exhibits152: Nipro Corp. – Overview
Exhibits153: Nipro Corp. – Business segments
Exhibits154: Nipro Corp. – Key offerings
Exhibits155: Nipro Corp. – Segment focus
Exhibits156: SONOTEC GmbH – Overview
Exhibits157: SONOTEC GmbH – Product / Service
Exhibits158: SONOTEC GmbH – Key offerings
Exhibits159: Terumo Group – Overview
Exhibits160: Terumo Group – Business segments
Exhibits161: Terumo Group – Key news
Exhibits162: Terumo Group – Key offerings
Exhibits163: Terumo Group – Segment focus
Exhibits164: Inclusions checklist
Exhibits165: Exclusions checklist
Exhibits166: Currency conversion rates for US$
Exhibits167: Research methodology
Exhibits168: Validation techniques employed for market sizing
Exhibits169: Information sources
Exhibits170: List of abbreviations



★調査レポート[人工心肺のグローバル市場2023~2027:病院、ASC] (コード:IRTNTR45350-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[人工心肺のグローバル市場2023~2027:病院、ASC]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆